🔎 Trials Near Me

Akèy › Neuroblastom › Colorado › Aurora

Etid klinik pou Neuroblastom nan Aurora, CO

8 etid pou Neuroblastom ap chèche patisipan nan sit nan ak bò kote Aurora (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ap rekriteFaz 3
  • Children's Hospital Colorado, Aurora
Jiska laj 30 · Tout sèks · Mizajou Oct 2, 2026 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Ap rekriteFaz 1/2
  • Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora
6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Ap rekriteFaz 3
  • Children's Hospital Colorado, Aurora
365 Days – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Children's Hospital Colorado, Aurora
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Ap rekriteFaz 2
  • Children's Hospital Colorado, Aurora
Laj 1 a 31 · Tout sèks · Mizajou Jul 20, 2026 · NCT06450041

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Ap rekriteFaz 1/2
  • Children's Hospital Colorado, Aurora
12 Months – 30 Years · Tout sèks · Mizajou May 19, 2026 · NCT04901702

Neuroblastoma Biology Study

Ap rekriteEtid obsèvasyon
  • Children Hospital of Colorado, Aurora
31 Days – 99 Years · Tout sèks · Mizajou Mar 23, 2026 · NCT01587300

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Ap rekriteFaz 2
  • Children's Hospital of Colorado, Aurora
18 Months – 40 Years · Tout sèks · Mizajou Aug 12, 2025 · NCT05135975

Etid Neuroblastom nan lòt vil

Lòt etid nan Aurora

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.